Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.metabol.2021.154814 http://scihub22266oqcxt.onion/10.1016/j.metabol.2021.154814 34119537!8192264!34119537     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Metabolism 2021 ; 121 (ä): 154814 Nephropedia Template TP {{tp|p=34119537|t=2021. Diabetes and COVID-19: The past, the present, and the future |pdf=|usr=}}{{34119537}} gab.com Text Diabetes and COVID-19: The past, the present, and the future JO: Metabolism http://www.kidney.de/pget.php?&tw=1&pmid=34119537 #FOAvip Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since the worse outcomes are closely associated with higher blood sugar levels in COVID-19 infection. Although recent observational studies showed that insulin was associated with mortality, it should not deter insulin use in hospitalized patients requiring tight glucose control. Back and forth dilemma in the past with regards to continue/discontinue certain medications used in diabetes have been mostly resolved. The initial fears of consequences related to continuing certain medications have been largely dispelled. COVID-19 also necessitates the transformation in diabetes care through the integration of technologies. Recent advances in health-related technologies, notably telemedicine and remote continuous glucose monitoring, have become essential in the management of diabetes during the pandemic. Today, these technologies have changed the landscape of medicine and become more important than ever. Being a high-risk population, patients with type 1 or type 2 diabetes, should be prioritized for vaccination. In the future, as the pandemic fades, the prevalence of non-communicable diseases is expected to rise due to lifestyle changes and medical issues/dilemma encountered during the pandemic. Twit Text FOAVip Diabetes and COVID-19: The past, the present, and the future ????Metabolism http://www.kidney.de/pget.php?&tw=1&pmid=34119537 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34119537 #FOAvip English Wikipedia <ref>{{Cite pmid|34119537}}</ref> Diabetes and COVID-19: The past, the present, and the future #MMPMID34119537 Pranata R; Henrina J; Raffaello WM; Lawrensia S; Huang I Metabolism 2021[Aug]; 121 (ä): 154814 PMID34119537show ga Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since the worse outcomes are closely associated with higher blood sugar levels in COVID-19 infection. Although recent observational studies showed that insulin was associated with mortality, it should not deter insulin use in hospitalized patients requiring tight glucose control. Back and forth dilemma in the past with regards to continue/discontinue certain medications used in diabetes have been mostly resolved. The initial fears of consequences related to continuing certain medications have been largely dispelled. COVID-19 also necessitates the transformation in diabetes care through the integration of technologies. Recent advances in health-related technologies, notably telemedicine and remote continuous glucose monitoring, have become essential in the management of diabetes during the pandemic. Today, these technologies have changed the landscape of medicine and become more important than ever. Being a high-risk population, patients with type 1 or type 2 diabetes, should be prioritized for vaccination. In the future, as the pandemic fades, the prevalence of non-communicable diseases is expected to rise due to lifestyle changes and medical issues/dilemma encountered during the pandemic. |*COVID-19/complications/epidemiology/mortality/prevention & control[MESH] |Blood Glucose Self-Monitoring[MESH] |Blood Glucose/metabolism[MESH] |COVID-19 Vaccines/administration & dosage[MESH] |Diabetes Mellitus, Type 1/*complications/drug therapy[MESH] |Diabetes Mellitus, Type 2/*complications/drug therapy[MESH] |Disease Susceptibility[MESH] |Humans[MESH] |Hypoglycemic Agents/therapeutic use[MESH] |Pandemics[MESH]Diabetes and COVID-19: The past, the present, and the future (epmc).pdf DeepDyve Pubget Overpricing